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Chronic heart failure (HF) is a complex condition associated with poor prognosis.1 In HF with 
reduced ejection fraction (HFrEF), V O2peak is a strong prognostic indicator for mortality, 
while at extremes of age, expressing V O2peak relative to age-predicted values is 
recommended.2 However, it can be difficult to achieve a peak exercise test and in such cases 
the relationship between ventilation ( V E) and carbon dioxide production ( V CO2) may be able 
to guide prognosis. An elevated V E/ V CO2 slope is associated with poor prognosis,2 while the 
exact  cut point might be modified by age.3 
 
There is evidence in HF that having a high body mass index (BMI) may paradoxically confer 
‘protection’ against mortality.4,5 Studies examining these prognostic indicators in HF suggest 
that this “obesity paradox” may be evident in those with low cardiopulmonary fitness ( V
O2peak), but less apparent when fitness is preserved.
6-9 We hypothesised that, in patients with 
HFrEF, elevated V E/ V CO2 slope would outperform V O2peak and BMI as a predictor of all-
cause mortality, and that those with a low V E/ V CO2 slope would have worse outcomes if they 
were also in the lower range for BMI. 
 
A retrospective analysis was conducted on cardiopulmonary exercise testing (CPET) data from 
312 HFrEF patients between 1997 and 2014. The study complied with the Declaration of 
Helsinki and was approved by Royal Perth Hospital Ethics Committee (REG 14-068). V
O2peak was assessed using an incremental CPET performed on a treadmill. Regression line of 
V E and V CO2 production was used to calculate V E/ V CO2 slope. Patients were characterized 
as having “higher fitness” or “lower fitness” with cut points for V O2peak at 14ml·kg-1·min-1, 
for age-predicted V O2peak at 50% and for V E/ V CO2 slope at 35. They were further 
characterised as having ‘normal BMI’ (18.5-25.0kg·m-2) or ‘high BMI’ (>25kg·m-2). This gave 
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four classifications: ‘normal BMI and lower fitness (or slope)’, ‘high BMI and lower fitness’, 
‘normal BMI and higher fitness’, or ‘high BMI and higher BMI’.  
 
All-cause mortality was documented from hospital records and a mortality database to May 
2016. Patients that received a cardiac transplant or ventricular assist device were censored. 
Baseline characteristics were calculated for the four fitness-overweight groups with one-way 
analysis and chi-square tests were conducted. Kaplan-Meier analysis was used to produce 
survival functions, which were compared between the groups using Log rank tests. Cox 
regression models were used for calculating hazard ratios (HR), using the fitness indicators as 
variables, expressed with 95% confidence intervals.  
 
Clinical characteristics of groups based on V O2peak (ml·kg·min-1) and BMI are reported in 
Table 1. All 3 fitness indicaters were independent predicters of mortality at 2 (p<0.01) and 5 
years (P<0.001). Having higher or lower BMI was not an independent predictor of mortality. 
Cox regression showed having a high V E/ V CO2 slope as the strongest predictor of mortality 
with HR of 6.83 (2.75-16.97) and 4.13 (2.34-7.25) for 2 and 5 years. Figure 1 shows survival 
for the different groups. Patients who had higher fitness based on V O2peak had better survival 
outcomes than their unfit counterparts, regardless of BMI. Whereas in the lower fitness group, 
those who had higher BMI had significantly higher survival those with normal BMI. When V
E/ V CO2 (≥ or <35) was used, lower slope patients had better survival than their higher slope 
counterparts, regardless of their BMI. V E/ V CO2 slope did not discriminate between the BMI 
categories in terms of survival. 
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Our findings confirm that fitness, and particularity ventilatory inefficiency (high V E/ V CO2 
slope), predicted mortality, whereas BMI did not. Those with elevated V E/ V CO2 (≥35) had 
lower survival, regardless of their BMI. These data confirm the prognostic significance of 
cardiopulmonary fitness and submaximal exercise derived ventilatory inefficiency. 
 
High BMI has been reported to convey a survival advantage in those with established HF and 
lower fitness.4,5,9 While we found this to be the case when fitness was stratisfied using V
O2peak, it was less apparent when using ventilatory efficiency. Our results add to the growing 
evidence that suggest the obesity paradox is mostly due to confounding factors.4,7,8  
 
The V E/ V CO2 slope has demonstrated to confer predictive capacity which may exceed that 
associated with V O2peak.2 our results indicate stronger predictive capacity for V E/ V CO2 
slope over V O2peak. These findings contribute to evidence that ventilatory inefficiency, 
derived from submaximal stages of a graded exercise test, are a valuable component of 
prognostic assessment for patients with HF. 
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Table 1. Characteristics of individuals with heart failure (HF) at the time of testing stratified based on V O2peak (ml·kg·min-1) and BMI.  
 Normal BMI, 
higher fitness  
(n=67) 
Normal BMI, 
lower fitness 
(n=30) 
 
High BMI, 
higher fitness 
 (n=146) 
High BMI, 
lower fitness 
 (n=69) 
P < 0.05* 
P < 0.01** 
Male, n (%)  50 (68) 19 (63) 129 (89) 58(84) NF vs HF*;NL vs HF*;  NL vs HL* 
Age, yrs (SD) 47 (15) 56 (15) 56 (10) 51(13) NS 
BMI, kg·m-2 (SD) 22.4 (1.7) 22.0 (1.6) 30.3 (3.6) 29.6 (3.3) NF vs HF**; HL vs NL**   
V O2peak , ml·kg-1·min-1 (SD) 21.1 (5.9) 11.1 (2.0) 20.4 (5.1) 11.3 (2.0) NF vs NL
**; HF vs HU** 
V O2peak % age-pred. (SD) 60 (15.0) 37 (8.2) 60 (12.9) 36 (6.8) NF vs NL
**HF vs HL** 
V E/ V C O2 slope 
Peak HR bpm (SD) 
Peak SBP mmHg (SD) 
Peak RER (SD) 
LVEF % (SD) 
34.4 (7.9)  
132 (36) 
121 (32) 
1.11(0.07) 
27 (12) 
48.9 (14.2)  
108 (26) 
111 (14) 
1.12 (0.07) 
27 (16) 
30.9 (5.8) 
138 (33) 
142 (20) 
1.12 (0.07) 
25 (10) 
39.9 (9.11) 
106 (33) 
114 (26) 
1.11(0.09) 
29 (12) 
NF vs NL**; HF vs HL** 
NF vs NL**; HF vs HL** 
NF vs NL**; HF vs HL** 
NS 
NS 
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NF, normal BMI, higher fitness; NL, normal BMI lower fitness; HF, high BMI, higher fitness; HL, high BMI, lower Fitness; SD, standard 
deviation; NS, not significant; BMI, body mass index; V O2peak, peak oxygen consumption; V E/ V C O2 slope, ratio ventilation:carbon dioxide 
output; HR, heart rate; bpm, beats per minute; SBP, systolic blood pressure, RER, respiratory exchange ratio; DBP, diastolic blood pressure; 
LVEF, left ventricular ejection fraction; NYHA, New York Heart Association; Hx, history  
NYHA class, (SD) 2.7 (0.84) 3.2 (0.58) 2.5 (0.84) 3.1 (0.79) NL vs NF*;  HL vs HF**; NF vs HF*; NL vs HF*;  
Ischaemic aetiology, % 25 28 30 54 HL vs HF; NF, NL** 
Hx hypertension, %  10 17 19 46 HL vs HF, NF, NL**; HF vs NF*; HL vs NL*   
Hx type 2 diabetes, % 3 14 16 33 HL vs HF, NF, NL** 
Hx hypercholesterolemia, % 9 7 17 30 HL vs HF, NF, NL** 
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Figure 1. (A) The effect of fitness, expressed as V O2peak ≥ or < 14 ml·kg-1·min-1 in patients 
who had high or low BMI, on mortality over 5 years. Higher fitness groups had lower 
mortality vs lower fitness groups, regardless of BMI, at both 2 and 5 years follow-
up (P<0.01). The lower fitness group with high BMI had lower mortality at 2 
(0=0.008) and 5 years (P=0.037) than the lower fitness with low BMI group.  
(B) The effect fitness, expressed as V O2peak ≥ or < 50% age-predicted in patients 
who had high or low BMI, on mortality over 5 years. Higher fitness groups had lower 
mortality than lower fitness groups, regardless of BMI at 2 and 5 years (P<0.01). 
The lower fitness group with high BMI had lower mortality at 2 (0=0.008) but not 5 
years (P=0.177) than the lower fitness with low BMI group.  
(C) The effect of ventilatory efficiency, expressed relative to V E/ V CO2 ≥ or < 35, in 
patients who had high or low BMI on all events over 5 years. Low slope subjects 
had lower mortality than a high slope subjects, regardless of whether they had normal 
BMI (P<0.001) or high BMI (P<0.05), over both 2 and 5 years. 
ISHLT and RPH AHFCTS post-transplant survival statistics are superimposed.10 
BMI, Body mass index; ISHLT, International Society for Heart & Lung 
Transplantation; RPH AHFCTS, Royal Perth Hospital Advanced Heart Failure and 
Cardiac Transplant Service; V E/ V C O2 slope, ratio ventilation:carbon dioxide 
output. 
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